FORENSIC TOXICOLOGY.NETOkorie Okorocha, J.D., M.S., M.S.Forensic Toxicology Expert Witness

EVIDENCE LIBRARY

Specimen Homogeneity and Aliquoting in Forensic Toxicology

By forensic toxicology working group members

How specimen homogeneity, aliquoting, mixing, postmortem blood, gastric contents, and repeat testing affect forensic toxicology interpretation.

Direct answer: A quantitative forensic toxicology result describes the aliquot that entered the analytical process. It is usually interpreted as representative of the submitted specimen, but that inference depends on appropriate specimen collection, mixing or homogenization when needed, aliquot selection, and documentation. When a specimen is heterogeneous, stratified, clotted, decomposed, visibly contaminated, or otherwise nonuniform, two aliquots can legitimately produce different results even when the analytical method itself is performing correctly.

This distinction matters in postmortem toxicology, impaired-driving testing, drug-facilitated crime investigations, and any case in which a concentration is compared with a cutoff, reference interval, prior result, or later reanalysis. The analytical instrument does not test the entire tube, organ, or gastric contents. It tests a small portion of material that is assumed to represent a larger specimen.

What does “representative aliquot” mean in forensic toxicology?

An aliquot is the portion of a specimen removed for analysis. A representative aliquot is one whose composition adequately reflects the specimen from which it was taken for the purpose of the test. That sounds simple, but biological materials are not always uniform.

Whole blood contains cellular and liquid phases. Postmortem blood may also contain clots, decomposition products, fat, sediment, or material from adjacent tissues. Gastric contents may contain fluid, food, partially dissolved tablets, and particulate matter. Tissues require sampling and often homogenization. Even urine or other fluids can contain precipitate or settled material after storage.

The central forensic question is therefore not merely whether the laboratory measured the aliquot accurately. It is also whether the aliquot was suitable for the conclusion being drawn about the larger specimen.

Why homogeneity matters

Homogeneity means that relevant components are distributed sufficiently uniformly for the sampling purpose. If an analyte or matrix component is unevenly distributed, the concentration in one portion may not equal the concentration in another.

This does not automatically invalidate a result. Instead, it changes what must be established before treating the reported concentration as representative. Appropriate mixing, homogenization, specimen-source documentation, and laboratory procedures become important parts of the evidentiary foundation.

ANSI/ASB Best Practice Recommendation 156 addresses specimen collection, amounts, preservatives, and storage conditions for forensic toxicology. A 2025 Journal of Analytical Toxicology best-practices paper applying current standards to postmortem toxicology specifically notes that representative gastric-content samples should be homogeneous mixtures and that visible pill material should be documented before homogenization. The same paper emphasizes careful documentation of specimen source and warns that postmortem blood may be affected by decomposition, clotting, pooling, fat contamination, and other factors.

Primary references: ANSI/ASB BPR 156 and Truver et al., Application of professional best practices in postmortem forensic toxicology (2025).

Whole blood is not automatically uniform

For quantitative blood testing, laboratories commonly mix the specimen before removing an aliquot. The purpose is not cosmetic. Mixing helps reduce the risk that settling, cellular distribution, clotting, or other physical separation makes the tested portion unrepresentative.

Case review should distinguish several different questions:

  • Was the specimen identified as whole blood, serum, plasma, or another matrix?
  • Was the tube adequately filled and preserved?
  • Was the specimen mixed before aliquoting?
  • Was clotting, sediment, phase separation, or visible contamination documented?
  • Was the specimen postmortem, and if so, from what anatomical source?
  • Did the laboratory validate the method for the matrix actually tested?

These issues complement, rather than replace, the laboratory’s method-validation, accuracy and precision, and quality-control requirements.

Postmortem blood adds a specimen-source problem

Postmortem blood is especially important because representativeness has two levels: the aliquot must represent the collected specimen, and the collected specimen must be understood in relation to its anatomical source.

Peripheral and central blood can differ because of postmortem redistribution and local contamination. The 2025 best-practices paper recommends preserving the source of blood during collection and notes that drawing large volumes from a vessel can create a mixed specimen by pulling blood from other locations. A well-mixed tube does not cure an uncertain or mixed anatomical source.

Accordingly, “the sample was mixed” and “the sample was representative” are not synonymous. Mixing can improve uniformity within the container. It cannot establish that the container itself reflects a particular anatomical compartment if the collection source is uncertain.

Gastric contents are a classic homogeneity problem

Gastric contents illustrate the issue clearly. A stomach may contain liquid, food, capsules, intact tablets, tablet fragments, or partially dissolved drug material. Removing 10 mL from one location before adequate homogenization may not represent the total contents.

For suspected overdose cases, documenting total volume and visible pill matter can be essential. Homogenization can make a subsample more representative of the bulk material, but the interpretation still depends on what question is being asked. A drug amount measured in gastric contents is not the same thing as an absorbed dose, and it does not by itself establish the amount originally ingested.

Tissue homogenates require a second layer of sampling

Tissue testing adds another sampling step. A portion of liver, brain, muscle, or other tissue is collected, and a smaller portion may then be homogenized for extraction. The reported concentration therefore depends on where the tissue was sampled, how the tissue was prepared, how the homogenate was mixed, and how the analytical aliquot was selected.

For a defensible quantitative interpretation, the laboratory record should permit a reviewer to understand the tissue source and the preparation procedure. This is particularly important when comparing concentrations between laboratories or between an original analysis and later reanalysis.

What can replicate agreement establish?

Agreement between replicate measurements is evidence of repeatability under the conditions used, but it does not prove that the specimen was homogeneous before the aliquots were taken. Two injections from the same extract, two measurements from the same prepared vial, and two independently prepared aliquots answer different questions.

For that reason, review the level at which replication occurred. The site’s detailed guide on repeat analysis and replicate agreement explains why reinjection, repeat extraction, and independent reanalysis are not interchangeable.

Can a result change after storage even if the aliquot was representative?

Yes. Representativeness and stability are separate issues. A perfectly representative aliquot can still change if an analyte degrades, converts, evaporates, adsorbs to a surface, or otherwise changes during storage. Conversely, a stable analyte can still be measured from a nonrepresentative aliquot.

These questions should therefore be evaluated independently. See Specimen Stability in Forensic Toxicology for storage temperature, preservative, freeze–thaw, degradation, and reanalysis considerations.

Why this matters near a cutoff or decision point

Representativeness becomes especially important when a measured concentration lies near a legal, administrative, laboratory, or interpretive threshold. Analytical uncertainty addresses variability associated with measurement. It does not automatically include every pre-analytical sampling problem.

If different portions of a heterogeneous specimen could yield materially different concentrations, that issue should not be collapsed into a generic instrument precision figure. Review the sampling and preparation record separately from the laboratory’s formal measurement-uncertainty evaluation.

For threshold cases, see Measurement Uncertainty Near Forensic Toxicology Cutoffs.

Case-review questions for specimen homogeneity and aliquoting

  • What exact specimen and matrix were received?
  • What anatomical collection site was documented?
  • Was the specimen visibly clotted, layered, decomposed, fatty, particulate, or otherwise nonuniform?
  • Was mixing or homogenization required by the laboratory procedure?
  • What type of mixing or homogenization was performed, and when?
  • Were aliquots taken before or after mixing?
  • How much specimen was used for each preparation?
  • Were duplicate aliquots prepared independently?
  • If repeat results differed, was heterogeneity considered during the investigation?
  • For gastric contents, was total volume recorded and visible pill material documented?
  • For tissue, what region was sampled and how was the homogenate prepared?
  • Was the method validated for the actual matrix and specimen condition?
  • Were storage and freeze–thaw history documented before reanalysis?

Frequently asked questions

Does mixing a blood tube guarantee a representative result?

No. Proper mixing can improve uniformity within the tube, but it does not resolve an uncertain specimen source, contamination during collection, degradation, or use of the wrong matrix-specific method.

If duplicate results agree, does that prove the specimen was homogeneous?

Not necessarily. The evidentiary value depends on how the duplicates were created. Replicate injections of one extract are much less informative about specimen homogeneity than independently prepared aliquots taken from a properly mixed or homogenized specimen.

Can gastric-content concentrations be used to calculate an ingested dose?

Only with substantial caution. Total volume, homogeneity, visible dosage forms, drug stability, incomplete absorption, vomiting, and unknown timing can all affect interpretation. The amount remaining in the stomach is not automatically the amount originally ingested.

Is aliquot representativeness part of measurement uncertainty?

Not automatically. A laboratory’s uncertainty evaluation is method- and measurand-specific. Pre-analytical sampling or specimen heterogeneity may require separate consideration unless those effects were actually incorporated into the validated uncertainty model.

Bottom line

A toxicology concentration should not be treated as though an instrument measured an entire specimen. The laboratory measured an aliquot. The strength of the broader inference depends on the scientific chain connecting the collected specimen to that aliquot: source, condition, mixing or homogenization, sampling, preparation, validation, stability, and quality control. In difficult cases, representativeness is a separate question worth evaluating rather than assuming.

References and standards